Evaluation of a Multi-disciplinary Approach for the Treatment of Hepatitis C in IDUs (HI-LO Study)

NACompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2010

Study Completion Date

December 31, 2012

Conditions
Hepatitis C Virus Infection
Interventions
DRUG

Interferon injections and ribavirin

Weekly pegylated interferon injections will be administered by clinic staff and ribavirin will be dispensed in weekly medication pack.

DRUG

Interferon injections and ribavirin

Patients will be offered the option of self or nurse administered pegylated interferon injections on an appointment basis. Ribavirin will be dispensed biweekly. The treatment medication cannot be stored at the clinic; it must be the subjects responsibility.

Trial Locations (1)

V6B 1R3

Pender Community Health Centre, Vancouver

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of British Columbia

OTHER

NCT00399672 - Evaluation of a Multi-disciplinary Approach for the Treatment of Hepatitis C in IDUs (HI-LO Study) | Biotech Hunter | Biotech Hunter